Lamivudine And Zidovudine Tablet
Product Images NDC 33342-003

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 33342-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lami (Lamizido Lamivudine)

Chemical structure of the active ingredient Lamivudine, showing the molecular arrangement including nitrogen, oxygen, sulfur atoms, and associated bonds in a dihydrothiazine ring and cytosine base.*

FDA Label Image

Zido (Lamizido Zidovudine)

Chemical structure diagram depicting the molecular structure of the active ingredient Lamivudine, showing atoms and bonds including a notable azide group (N3) and a carbonyl group (C=O).*

FDA Label Image

505 (Lami Zido 150 300mg 60s)

Label for Lamivudine and Zidovudine Tablets USP 150 mg/300 mg oral tablets. The label indicates a 60-tablet count and includes manufacturer information: Macleods Pharma USA, Inc. (Princeton, NJ) and Macleods Pharmaceuticals Ltd. (Daman, India). Storage instructions and dosage references are partially visible along with barcodes.*

FDA Label Image

505 (Lami Zido 150 300 60s Unit Dose Blister)

Packaging label for Lamivudine and Zidovudine Tablets, USP 150 mg/300 mg by Macleods Pharmaceuticals Limited. The label includes the proprietary name, dosage strength, unit-dose packaging quantity (60 tablets in 6 x 10), and manufacturing information. It also notes storage conditions and indicates the product is Rx only.*

FDA Label Image

505 (Lami Zido 150 300 120s Unit Dose Blister)

Packaging label for Lamivudine and Zidovudine Tablets, USP, 150 mg/300 mg strength, manufactured by Macleods Pharmaceuticals Limited. The label indicates the product contains 120 tablets in a unit-dose arrangement, with storage and manufacturing details included. The label shows the NDC 33342-003-25 and features the Macleods Pharma USA logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.